In March, the US FDA issued a final rule to ban the use of electrical aversion therapy to treat self-injurious or aggressive behaviour in neuroatypical patients. This is one of only three types of devices to be banned by the regulator since its inception in 1906. To find out what led to this historic ruling, we chart the rise and fall of one of healthcare’s most controversial practises.
Also, with demand for Covid-19 tests growing, we examine the reliability and accessibility of home-testing products, find out how a collaboration between the Rwandan Government and Babylon Health is helping to transform the country’s healthcare system and establish Africa’s first digital-first universal primary care service, and take a look at the future of smart ambulances with O&H Vehicle Technology.
